FBR lists prime takeover candidates in biotech Mar. 6, 2017 9:13 AM • SA Editor Douglas W. House FBR's Chris Meekins says the potential for tax reform and FDA policy changes could stoke biotech M&A activity. His short list of leading takeover candidates: TESARO (NASDAQ:TSRO), Agile Therapeutics (NASDAQ:AGRX); Kite Pharma (NASDAQ:KITE), Juno Therapeutics (NASDAQ:JUNO); Acceleron Pharma (NASDAQ:XLRN); Aurinia Pharmaceuticals (NASDAQ:AUPH), Geron (NASDAQ:GERN) and Genocea (NASDAQ:GNCA). Source: StreetInsider
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.